The relationship between the genetic polymorphism of CYP2C19*2?*3 and the clinical efficacy of clopidogrel: a systematic review
- At: 2012 FIP Congress in Amsterdam (the Netherlands)
- Type: Poster
- By: YANG, Liping (Beijing Hospital, Ministry of Health, Department of Pharmacy, Beijing, China)
OBJECTIVE: To evaluate anti-platelet effect of clopidogrel influenced by CYP2C19*2,*3 polymorphism in patients with cardiovascular disease...
METHODS: The literatures were searched from the following electronic databases: EMBase, PubMed, Cochrane Library, China Biological Medicine Database (CBM) and the Chinese Journal Network Database (CNKI), with The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.